TM Publications Post 2000

  

General

  1. Grob P, Jilg W, Bornhak H, Gerken G, Gerlich W, Gunther S, Hess G, Hudig H, Kitchen A, Margolis H, Michel G, Trepo C, Will H, Zanetti A, Mushahwar I. (2000) Serological pattern "anti-HBc alone" report on a workshop. J Med Virol. : 62,450-5.
  2. Barbara J. (2000) Prions and blood transfusion. Transfus Sci: 22,49
  3. Caspari G, Barbara JA. (2000) Anti-HEV in blood donors: what is test and what is virus? Vox Sang: 78,198-9.
  4. Grant PR, Kitchen A, Barbara JA, Hewitt P, Sims CM, Garson JA, Tedder RS. (2000) Effects of handling and storage of blood on the stability of hepatitis C virus RNA: implications for NAT testing in transfusion practice. Vox Sang: 78,137-42.
  5. Stanworth SJ, Warwick RM, Ferguson M, Barbara JA. (2000) A UK survey of virological testing of cadaver tissue donors. Microbiology Working Group of the NIBSC steering group on Tissue/Cell Banking and Engineering. Vox Sang: 79,227-30.
  6. Barbara J. (2000) Surrogate tests. Vox Sang: 78 Suppl 2,63-5
  7. Barbara J. (2001) The rationale for pathogen inactivation treatment of platelet components--introduction. Semin Hematol: 38 (Suppl 11),1-3
  8. Barbara J, Seghatchian J. (2001) Prioritizing the options for enhancing blood component safety. Transfus Apheresis Sci: 25,225
  9. Eglin R. (2001) Enhanced arm cleansing, diversion of the first aliquot of donation, NAT and their impact on blood safety. Transfus Apheresis Sci.: 25,175
  10. Fogden M, Whitehorn K, Starr D, Persaud R, Hannaford R, Barbara J, Love E, Robinson A, Ferguson E, Turner G, Wallington T, Klein H, Franklin I, Fry R. (2001) Panel Discussion. Millennium Festival of Medicine--Transfusion 2020--18 October 2000. Transfus Med: 11,136-45
  11. Price J, Cant BA, Barbara JA, Tedder RS. (2001) Human T-cell leukaemia/lymphoma virus risk may be enhanced in some selected donor populations. Vox Sang: 80,148-50.
  12. Tedder RS, Ijaz S, Gilbert N, Barbara JA, Corden SA, Gilson RJ, Boxall EH. (2002) Evidence for a dynamic host-parasite relationship in e-negative hepatitis B carriers. J Med Virol: 68,505-12
  13. Barbara J, Eglin R. (2002) Genome detection and transfusion: setting the scene. Transfus Med: 12,227-8
  14. Eglin R. (2002) Implementation of genome amplification technology for HCV RNA detection. Transfus Med. : 12,265-73.
  15. Reesink HW, Engelfriet CP, Tegtmeier GE, O'Riordan J, Eglin R, Barbara JA, Flanagan P, Lin CK, Rawlinson W, Muylle L, Wendel S, Biagini S, Lazar AE, Krusius T, Alitupa E, Grillner L, Preiser W, Doerr HW, Brand A, Zupanska B, Brojer E, Degre M. (2002) Prevention of post-transfusion cytomegalovirus: leucoreduction or screening? Vox Sang: 83,72-87.
  16. Grant PR, Sims CM, Krieg-Schneider F, Love EM, Eglin R, Tedder RS. (2002) Automated screening of blood donations for hepatitis C virus RNA using the Qiagen BioRobot 9604 and the Roche COBAS HCV Amplicor assay. Vox Sang.: 82,169-76.
  17. Corden S, Ballard AL, Ijaz S, Barbara JA, Gilbert N, Gilson RJ, Boxall EH, Tedder RS. (2003) HBV DNA levels and transmission of hepatitis B by health care workers. J Clin Virol: 27,52-8.
  18. Candotti D, Richetin A, Cant B, Temple J, Sims C, Reeves I, Barbara JA, Allain JP. (2003) Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system. Transfusion.: 43,215-25.

Back to top


Transfusion Microbiology

  1. Kitchen AD, Barbara JA: Transfusion transmitted Infections. In: Practical Transfusion Medicine Eds Murphy MF, Pamphilon DH. Blackwell Science 2001
  2. Barbara J. The rationale for pathogen inactivation treatment of platelet components-introduction. Seminars in Hematology Oct. 2001;38(4 Suppl 11):1-3.
  3. Fogden M, Whitehorn K, Starr D, Persaud R, Hannaford R, Barbara J, Love E, Robinson A, Ferguson E, Turner G, Wallington T, Klein H, Franklin I, Fry R. Panel Discussion. Millennium Festival of Medicine-Transfusion 2020-18 October 2000.Transfusion Medicine, Apr 2001;11(2):136-45.
  4. Kitchen AD, Barbara JA. (2000) Which agents threaten blood safety in the future? Baillieres Best Pract Res Clin Haematol: 13,601-14
  5. Kitchen A. (2000) Cautionary note. Vox Sang.: 78,132
  6. Barbara JA. (2001) Transfusion transmitted infections. Tumori.: 87,S8-10.

Back to top


Bacteriology

  1. Engelfriet CP, Reesink HW, Blajchman MA, Muylle L, Kjeldsen-Kragh J, Kekomaki R, Yomtovian R, Hocker P, Stiegler G, Klein HG, Soldan K, Barbara J, Slopecki A, Robinson A, Seyfried H. (2000) Bacterial contamination of blood components. Vox Sang: 78,59-67
  2. McDonald CP, Roy A, Lowe P, Robbins S, Hartley S, Barbara JAJ. Evaluation of the Bact/Alert automated blood culture system for detecting bacteria and measuring their growth kinetics in leucodepleted and non-leucodepleted platelet concentrates. Vox Sanguinis 2001 81: 154-160.
  3. McDonald CP, Lowe P, Roy A, Robbins S, Hartley S, Harrison JF, Slopecki A, Verlander N, Barbara JAJ. Evaluation of donor arm disinfection techniques. Vox Sanguinis 2001 80:135-141.
  4. McDonald CP, Roy A, Lowe P, Robbins S, Hartley S, Barbara JA. (2001) Evaluation of the BacT/Alert automated blood culture system for detecting bacteria and measuring their growth kinetics in leucodepleted and non-leucodepleted platelet concentrates. Vox Sang: 81,154-60.
  5. McDonald CP, Rogers A, Cox M, Smith R, Roy A, Robbins S, Hartley S, Barbara JA, Rothenberg S, Stutzman L, Widders G. (2002) Evaluation of the 3D BacT/ALERT automated culture system for the detection of microbial contamination of platelet concentrates. Transfusion: 12,303-9.
  6. McDonald C. (2003) International forum 12: Detection of Bacterial Contamination Platelet Concentrates Vox Sang.: 85,238-9.

Back to top

 

Surveillance and Epidemiology

  1. Barbara J, Moore MC, Hewitt PE. (2000) Prevalence of antibodies to HTLV in blood donors in north London. BMJ: 320,650
  2. Regan FA, Hewitt P, Barbara JA, Contreras M. (2000) Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood. TTI Study Group. BMJ.: 12,320
  3. Barbara J, Galea G, Warwick R. (2000) Prevalence of HIV and hepatitis C markers among a cadaveric population in Milan. J Clin Pathol: 53,405
  4. Howell DR, Webster MH, Barbara JA. (2000) Retrospective follow-up of recipients and donors of blood donations reactive for anti-HBc or for single HCV antibodies. Transfus Med: 10,265-9.
  5. Whitby K, Ferns RB, Garson JA, Bailey M, Howell D, Barbara JA, Tedder RS. (2000) GBV-C prevalence in blood donors and transfusion recipients in South East England. Vox Sang: 79,246
  6. Salker R, Howell DR, Moore MC, Kitchen AD. (2001) Early acute hepatitis B infection and hepatitis B vaccination in blood donors. Transfus Med. : 11,463
  7. Soldan K, Barbara JA, Dow BC. (2002) Transfusion-transmitted hepatitis B virus infection in the UK: a small and moving target. Vox Sang: 83,305-8
  8. Moore C, Barbara J, Hewitt P. (2002) Antibodies to hepatitis B core in Danish blood donors: a surrogate marker for 'high-risk' behaviour? Vox Sang: 82,161
  9. Soldan K, Barbara JA, Ramsay ME, Hall AJ. (2003) Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001. Vox Sang: 84,215-25
  10. Soldan K, Sinka K. (2003) Evaluation of the de-selection of men who have had sex with men from blood donation in England. Vox Sang. 84(4):265-73.
  11. Soldan K, Davison K, Dow B. (2005) Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003. Euro Surveill. 10(2):17-9
  12. Soldan K. (2005) UK blood donors identified as at increased risk of vCJD are to be notified of their status. Euro Surveill. Jul 21;10(7).
  13. Brant LJ, Bukasa A, Davison KL, Newham J, Barbara JA. (2007) Increase in recently acquired syphilis infections in English, Welsh and Northern Irish blood donors. Vox Sang. 93(1):19-26.
  14. Brant LJ, Davison KL. (2008) Infections detected in English surgical bone and deceased donors (2001-2006) and estimated risk of undetected hepatitis B and hepatitis C virus. Vox Sang. 95(4):272-9

Back to top

Also see